Mercodia

Mercodia is a biopharma company with a slogan of "Expertise that matters." Established in 1991 and headquartered in Sweden, the company brings over 30 years of experience to the table as a leading manufacturer of cardiometabolic immunoassays. It specializes in tailored bioanalysis solutions for pharma and biotech companies, focusing on assay development and validation, PK/PD, immunogenicity testing, and biomarker testing for large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. Mercodia's commitment to quality is evident through its GLP certification and compliance with ICH GCP, EMA, and FDA guidelines. The company's team of expert scientists is dedicated to delivering reproducible, reliable, and high-quality data that meets regulatory requirements. Moreover, a key focus is placed on speed, flexibility, and cost-effectiveness in providing solutions. With the vision of improving human health globally, Mercodia operates from its manufacturing and service lab facilities in Uppsala, Sweden, and Winston-Salem, USA. The company has established itself as a trusted partner to renowned universities, pharmaceutical, and biotech companies worldwide, demonstrating its potential for growth and impact in the healthcare and manufacturing industries. While no recent investment information is available, Mercodia's expertise and strong positioning in the market position the company as an attractive prospect for potential investors.